nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

10.11.2023 | Miscellaneous

The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer

verfasst von: Serdar Ata, Nur Yücel Ekici, Mahmut Büyükşimşek, Timuçin Çil, Berna Bozkurt Duman

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

The study aims to investigate the estrogen-agonistic effects of tamoxifen on voice parameters in premenopausal women diagnosed with breast cancer.

Methods

A total of 108 premenopausal women were included, segmented into distinct treatment groups and a control group. Objective sound analysis was conducted using robust statistical methods, employing SPSS 25.0 for data analysis.

Results

The study identified a statistically significant reduction in Jitter values across all treatment groups compared to the control group. No significant changes were observed in other voice quality parameters such as F0, Shimmer, NHR, and HNR.

Conclusions

The findings suggest that tamoxifen may have an estrogen-agonistic effect on voice quality, thereby potentially influencing future treatment protocols. This research fills a critical void in existing literature and sets the stage for more comprehensive studies that consider affects of hormonal therapies to voice.

Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852–856. https://doi.org/10.1056/NEJM199203263261302CrossRefPubMed

Satyaswaroop PG, Zaino RJ, Mortel R (1984) Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 44:4006–4010PubMed

Neven P, Vergote I (2001) Tamoxifen, screening and new oestrogen receptor modulators. Best Pract Res Clin Obstet Gynaecol 15:365–380. https://doi.org/10.1053/beog.2001.0182CrossRefPubMed

Chae SW, Choi G, Kang HJ, Choi JO, Jin SM (2001) Clinical analysis of voice change as a parameter of premenstrual syndrome. J Voice 15:278–283. https://doi.org/10.1016/S0892-1997(01)00028-5CrossRefPubMed

Çelik Ö, Çelik A, Ateşpare A, Boyacı Z, Çelebi Ş, Gündüz T, Aksungar FB, Yelken K (2013) Voice and speech changes in various phases of menstrual cycle. J Voice 27:622–626. https://doi.org/10.1016/j.jvoice.2013.02.006CrossRefPubMed

Pavela Banai I (2017) Voice in different phases of menstrual cycle among naturally cycling women and users of hormonal contraceptives. PLoS ONE 12:e0183462. https://doi.org/10.1371/journal.pone.0183462CrossRefPubMedPubMedCentral

Fischer J, Semple S, Fickenscher G, Jürgens R, Kruse E, Heistermann M, Amir O (2011) Do women’s voices provide cues of the likelihood of ovulation? The importance of sampling regime. PLoS ONE 6:e24490. https://doi.org/10.1371/journal.pone.0024490CrossRefPubMedPubMedCentral

Tatar EC, Sahin M, Demiral D, Bayir O, Saylam G, Ozdek A, Korkmaz MH (2016) Normative values of voice analysis parameters with respect to menstrual cycle in healthy adult Turkish women. J Voice 30:322–328. https://doi.org/10.1016/j.jvoice.2015.04.014CrossRefPubMed

Schneider B, Van Trotsenburg M, Hanke G, Bigenzahn W, Huber J (2004) Voice impairment and menopause. Menopause 11:151–158. https://doi.org/10.1097/01.GME.0000094192.24934.46CrossRefPubMed

10.

Hamdan A-L, Ziade G, Tabet G, Btaiche R, Fakhri G, Yatim F, Sarieddine D, Seoud M (2017) Vocal symptoms and acoustic findings in menopausal women in comparison to pre-menopause women with body mass index as a confounding variable. J Menopausal Med 23:117. https://doi.org/10.6118/jmm.2017.23.2.117CrossRefPubMedPubMedCentral

11.

Raj A, Gupta B, Chowdhury A, Chadha S (2010) A study of voice changes in various phases of menstrual cycle and in postmenopausal women. J Voice 24:363–368. https://doi.org/10.1016/j.jvoice.2008.10.005CrossRefPubMed

12.

Schneider B, Cohen E, Stani J, Kolbus A, Rudas M, Horvat R, Van Trotsenburg M (2007) Towards the expression of sex hormone receptors in the human vocal fold. J Voice 21:502–507. https://doi.org/10.1016/j.jvoice.2006.01.002CrossRefPubMed

13.

Tatlıpınar A, Güneş P, Özbeyli D, Çimen B, Gökçeer T (2011) Effects of ovariectomy and estrogen replacement therapy on laryngeal tissue: a histopathological experimental animal study. Otolaryngol Head Neck Surg 145:987–991. https://doi.org/10.1177/0194599811423638CrossRefPubMed

14.

Caruso S, Roccasalva L, Sapienza G, Zappalá M, Nuciforo G, Biondi S (2000) Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy. Fertil Steril 74:1073–1079. https://doi.org/10.1016/S0015-0282(00)01582-XCrossRefPubMed

15.

Amir O, Kishon-Rabin L, Muchnik C (2002) The effect of oral contraceptives on voice. J Voice 16:267–273. https://doi.org/10.1016/S0892-1997(02)00096-6CrossRefPubMed

16.

Boersma P, Van Heuven V (2001) Speak and unSpeak with PRAAT. Glot Int 5:341–347

17.

Amir O, Kishon-Rabin L (2004) Association between birth control pills and voice quality. Laryngoscope 114:1021–1026. https://doi.org/10.1097/00005537-200406000-00012CrossRefPubMed

18.

Lã FMB, Ardura D (2022) What voice-related metrics change with menopause? A systematic review and meta-analysis study. J Voice 36(438):e1-438.e17. https://doi.org/10.1016/j.jvoice.2020.06.012CrossRef

19.

D’haeseleer E, Depypere H, Van Lierde K (2013) Comparison of speaking fundamental frequency between premenopausal women and postmenopausal women with and without hormone therapy. Folia Phoniatr Logop 65:78–83. https://doi.org/10.1159/000350405CrossRefPubMed

20.

Voelter Ch, Kleinsasser N, Joa P, Nowack I, Martínez R, Hagen R, Voelker HU (2008) Detection of hormone receptors in the human vocal fold. Eur Arch Otorhinolaryngol 265:1239–1244. https://doi.org/10.1007/s00405-008-0632-xCrossRefPubMed

21.

Newman S-R, Butler J, Hammond EH, Gray SD (2000) Preliminary report on hormone receptors in the human vocal fold. J Voice 14:72–81. https://doi.org/10.1016/S0892-1997(00)80096-XCrossRefPubMed

22.

Kirgezen T, Sunter AV, Yigit O, Huq GE (2017) Sex hormone receptor expression in the human vocal fold subunits. J Voice 31:476–482. https://doi.org/10.1016/j.jvoice.2016.11.005CrossRefPubMed

23.

Nacci A, Fattori B, Basolo F, Filice ME, De Jeso K, Giovannini L, Muscatello L, Matteucci F, Ursino F (2011) Sex hormone receptors in vocal fold tissue: a theory about the influence of sex hormones in the larynx. Folia Phoniatr Logop 63:77–82. https://doi.org/10.1159/000316136CrossRefPubMed

24.

Cohen E, Kolbus A, Van Trotsenburg M, Rudas M, Horvat R, Schneider B (2009) Immunohistochemical examinations of sex hormone receptors in benign vocal fold lesions. Folia Phoniatr Logop 61:259–262. https://doi.org/10.1159/000235647CrossRefPubMed

25.

Ferrandina G, Almadori G, Maggiano N, Lanza P, Ferlini C, Cattani P, Piantelli M, Scambia G, Ranelletti FO (1998) Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors. Int J Cancer 77:747–754. https://doi.org/10.1002/(SICI)1097-0215(19980831)77:5%3c747::AID-IJC14%3e3.0.CO;2-ZCrossRefPubMed

26.

Raspaglio G, Ferrandina G, Ferlini C, Scambia G, Ranelletti FO (2003) Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 ıs more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effects. Oncol Res 14:83–91. https://doi.org/10.3727/000000003108748630CrossRefPubMed

27.

Schwartz N, Verma A, Muktipaty C, Bivens C, Schwartz Z, Boyan BD (2019) Estradiol receptor profile and estrogen responsiveness in laryngeal cancer and clinical outcomes. Steroids 142:34–42. https://doi.org/10.1016/j.steroids.2017.11.012CrossRefPubMed

28.

Robbins KT, Vu TP, Diaz A, Varki NM (1994) Growth effects of tamoxifen and estradiol on laryngeal carcinoma cell lines. Arch Otolaryngol Head Neck Surg 120:1261–1266. https://doi.org/10.1001/archotol.1994.01880350067012CrossRefPubMed

29.

Moon Z, Hunter MS, Moss-Morris R, Hughes LD (2017) Factors related to the experience of menopausal symptoms in women prescribed tamoxifen. J Psychosom Obstet Gynecol 38:226–235. https://doi.org/10.1080/0167482X.2016.1216963CrossRef

30.

Arnold BJ, Cumming CE, Lees AW, Handman MD, Cumming DC, Urion C (2001) Tamoxifen in breast cancer: symptom reporting. Breast J 7:97–100. https://doi.org/10.1046/j.1524-4741.2001.007002097.xCrossRefPubMed

31.

Zidan J, Keidar Z, Basher W, Israel O (2004) Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer. MO 21:117–122. https://doi.org/10.1385/MO:21:2:117CrossRef

32.

Shrivastava D (2014) Impact of sleep-disordered breathing treatment on upper airway anatomy and physiology. Sleep Med 15:733–741. https://doi.org/10.1016/j.sleep.2014.01.002CrossRefPubMed

Titel: The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer
verfasst von: Serdar Ata
Nur Yücel Ekici
Mahmut Büyükşimşek
Timuçin Çil
Berna Bozkurt Duman
Publikationsdatum: 10.11.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2024
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-023-08328-8

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer

Abstract

Objective

Methods

Results

Conclusions

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2024

Serum levels of heavy metals in patients with Bell’s palsy: a case–control study

Artificial intelligence chatbots as sources of patient education material for obstructive sleep apnoea: ChatGPT versus Google Bard

Comments on: Value and role of surgical margins in transoral laser microsurgery of the larynx, literature review and clinical considerations

Does skin prick test response intensity predict symptom severity and efficacy of subcutaneous immunotherapy in allergic rhinitis?

Cochlear implantation in Bjornstad syndrome: a case series with literature review

Construction of a nomogram for central lymph node metastasis in papillary thyroid cancer based on gender grouping

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO